<label id="xi47v"><meter id="xi47v"></meter></label>
       
      Chinese scientists find therapy in osteoporosis drug for breast cancer
                       Source: Xinhua | 2018-05-05 02:10:58 | Editor: huaxia

      Basal-like breast cancer cells form multiple metastatic tumors (arrowheads) in the lungs of control mice (left), but metastasis is suppressed by zoledronic acid treatment (right). (Credit: Cao et al)

      WASHINGTON, May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a particular aggressive form of breast cancer that typically affects younger, premenopausal women.

      A study published on Friday in the Journal of Experimental Medicine revealed that the zoledronic acid could inhibit UGT8 or UDP Glycosyltransferase 8, an enzyme that drives the progression of basal-like breast cancer.

      The Basal-like breast cancer is largely untreatable because the tumor cells are usually lacking the estrogen receptor, progesterone receptor, and HER2 protein that are the main therapeutic targets for other forms of breast cancer.

      The researchers from Zhejiang University School of Medicine examined over 5,000 breast cancer patient samples and found that levels of the metabolic enzyme UGT8 were dramatically elevated in patients with basal-like breast cancer.

      Higher UGT8 levels correlated with increased tumor size, higher tumor grade, and shorter patient survival times, according to the study.

      UGT8 catalyzes the first step in the synthesis of sulfatide, a type of lipid that is found on the surface of cells and has been implicated in cancer progression.

      Dong Chenfang, an oncologist professor with Zhejiang University, and his colleagues found that breast cancer cells expressing high levels of UGT8 produced large amounts of sulfatide, which in turn activated signaling pathways crucial for the survival and metastasis of basal-like breast cancer.

      The researchers also found that depleting UGT8 from these cells lowered sulfatide levels and reduced the cells' ability to form tumors when injected into mice.

      They confirmed that zoledronic acid is a direct inhibitor of UGT8 that reduces the levels of sulfatide in basal-like breast cancer cells. Zoledronic acid is a drug that is approved to treat a variety of bone diseases, including osteoporosis.

      Treatment with the drug impaired the cells' ability to invade their surroundings and, accordingly, prevented them from metastasizing to the lungs after they were injected into the mice.

      "Pharmacological inhibition of UGT8 by zoledronic acid offers a promising opportunity for the clinical treatment of this challenging disease," Dong said.

      Back to Top Close
      Xinhuanet

      Chinese scientists find therapy in osteoporosis drug for breast cancer

      Source: Xinhua 2018-05-05 02:10:58

      Basal-like breast cancer cells form multiple metastatic tumors (arrowheads) in the lungs of control mice (left), but metastasis is suppressed by zoledronic acid treatment (right). (Credit: Cao et al)

      WASHINGTON, May 4 (Xinhua) -- Chinese researchers discovered that a widely-used osteoporosis drug might prevent the spread of a particular aggressive form of breast cancer that typically affects younger, premenopausal women.

      A study published on Friday in the Journal of Experimental Medicine revealed that the zoledronic acid could inhibit UGT8 or UDP Glycosyltransferase 8, an enzyme that drives the progression of basal-like breast cancer.

      The Basal-like breast cancer is largely untreatable because the tumor cells are usually lacking the estrogen receptor, progesterone receptor, and HER2 protein that are the main therapeutic targets for other forms of breast cancer.

      The researchers from Zhejiang University School of Medicine examined over 5,000 breast cancer patient samples and found that levels of the metabolic enzyme UGT8 were dramatically elevated in patients with basal-like breast cancer.

      Higher UGT8 levels correlated with increased tumor size, higher tumor grade, and shorter patient survival times, according to the study.

      UGT8 catalyzes the first step in the synthesis of sulfatide, a type of lipid that is found on the surface of cells and has been implicated in cancer progression.

      Dong Chenfang, an oncologist professor with Zhejiang University, and his colleagues found that breast cancer cells expressing high levels of UGT8 produced large amounts of sulfatide, which in turn activated signaling pathways crucial for the survival and metastasis of basal-like breast cancer.

      The researchers also found that depleting UGT8 from these cells lowered sulfatide levels and reduced the cells' ability to form tumors when injected into mice.

      They confirmed that zoledronic acid is a direct inhibitor of UGT8 that reduces the levels of sulfatide in basal-like breast cancer cells. Zoledronic acid is a drug that is approved to treat a variety of bone diseases, including osteoporosis.

      Treatment with the drug impaired the cells' ability to invade their surroundings and, accordingly, prevented them from metastasizing to the lungs after they were injected into the mice.

      "Pharmacological inhibition of UGT8 by zoledronic acid offers a promising opportunity for the clinical treatment of this challenging disease," Dong said.

      010020070750000000000000011105091371567321
      主站蜘蛛池模板: 久久久久久久久久免免费精品| 免费黄网站在线观看| 亚洲Av无码乱码在线播放| 国产日韩AV免费无码一区二区三区 | 亚洲成?v人片天堂网无码| 99re8这里有精品热视频免费| 日本久久久久亚洲中字幕| 在线观看无码的免费网站| 久久国产精品免费一区| 亚洲无码一区二区三区| 亚洲日韩乱码中文无码蜜桃臀网站| 波多野结衣在线免费视频| 国产人成网在线播放VA免费| va天堂va亚洲va影视中文字幕 | 亚洲小说图区综合在线| 亚洲熟妇中文字幕五十中出| 国产免费不卡v片在线观看| 在线播放免费人成视频网站| 亚洲国产一区在线观看 | 免费观看亚洲人成网站| 日韩亚洲Av人人夜夜澡人人爽 | 国产一区视频在线免费观看| 91香蕉国产线观看免费全集| 美女隐私免费视频看| 亚洲综合久久一本伊伊区| 情人伊人久久综合亚洲| 国产又粗又长又硬免费视频| 69免费视频大片| 国产一二三四区乱码免费| 羞羞漫画在线成人漫画阅读免费| 91嫩草亚洲精品| 亚洲成a人片77777kkkk| 亚洲国产成人久久一区WWW| 成年女性特黄午夜视频免费看| 华人在线精品免费观看| 人人爽人人爽人人片A免费| 亚洲av无码专区在线电影天堂| 久久久久亚洲AV无码观看| 亚洲国产精品无码av| 久久亚洲国产成人精品无码区| 国产免费变态视频网址网站|